Intelligence Platform
Patents
Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7388089
Anti-arthropod vector vaccines method of selecting and uses thereof
granted patentUS 7381744
Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds
granted patentUS 7381405
Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment
granted patentUS 7378403
Akt inhibitors, pharmaceutical compositions, and uses thereof
granted patentUS 7378277
Methods and compositions for transforming dendritic cells and activating T cells
granted patentUS 7378276
Method of inducing memory B cell development and terminal differentiation
granted patentUS 7378257
Bacterial superantigen vaccines
granted patentUS 7378097
Use of penetration enhancers and barrier disruption methods to enhance the immune response
granted patentUS 7378093
Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus select
granted patentUS 7375185
Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use
granted patentUS 7375079
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus ne
granted patentUS 7374931
Vaccine against staphylococcus intoxication
granted patentUS 7374872
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
granted patentUS 7374756
Specific binding agents for KSHV vIL-6 that neutralize a biological activity
granted patentUS 7371572
Mouse titers after two immunizations with VLPs alone
granted patentUS 7371392
Cd40 ligand adjuvant for respiratory syncytial virus
granted patentUS 7371385
Method of treating immune pathologies with low dose estrogen
granted patentUS 7371225
Method for convection enhanced delivery of therapeutic agents
granted patentUS 7368116
Method of enhancing a targeted immune response against tumors
granted patentUS 7368114
Fusion protein including of CD4
granted patentUS 7368110
Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for
granted patentUS 7368106
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment
granted patentUS 7368100
Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and me
granted patentUS 7364719
Vasoregulating compounds and methods of their use
granted